Transcriptomic and immunologic implications of the epithelial–mesenchymal transition model reveal a novel role of SFTA2 in prognosis of non-small-cell lung carcinoma

Transcriptomic and immunologic implications of the epithelial–mesenchymal transition model reveal a novel role of SFTA2 in prognosis of non-small-cell lung carcinoma

Non-small-cell lung cancer (NSCLC) is the second most common cancer worldwide, and most deaths are associated with epithelial–mesenchymal transition (EMT). Therefore, this study aimed to explore the role of EMT-related transcriptomic profiles in NSCLC and the effect of EMT-based signatures on clinic...

Full description

Bibliographic Details
Main Authors: Na Li, Zhanqiang Zhai, Yuanbiao Chen, Xiaofeng Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Genetics
Subjects:
epithelial–mesenchymal transition (EMT)
non-small-cell lung cancer (NSCLC)
SFTA2
prognosis
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.911801/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.911801/full

Similar Items